Trusted by over 10K subscribers
    Free & discreet shipping on all prescriptions
    Affordable pricing with no hidden fees
    FDA-regulated pharmacies
    100% online process
    Trusted by over 10K subscribers
    Free & discreet shipping on all prescriptions
    Affordable pricing with no hidden fees
    FDA-regulated pharmacies
    100% online process
    Trusted by over 10K subscribers
    Free & discreet shipping on all prescriptions
    Affordable pricing with no hidden fees
    FDA-regulated pharmacies
    100% online process
    HomeMedication GuideSLU-PP-332 safety
    Estrogen-related receptor (ERRα/γ) agonist — research compoundInvestigational / Not FDA-Approved

    SLU-PP-332: Patient Information & Safety Notes

    Also known as SLU PP 332, ERR agonist SLU-PP-332

    Other names: err-agonist-slu-pp-332

    SLU-PP-332 is a synthetic small molecule that selectively activates estrogen-related receptors (ERRα and ERRγ), which regulate mitochondrial biogenesis and energy metabolism. It has been proposed as an "exercise mimetic" in preclinical studies. It has no human clinical data.

    NOT FDA-approved. SLU-PP-332 exists only in preclinical research. No human clinical trials have been conducted. Its safety, pharmacokinetics, and effects in humans are entirely unknown.
    Reviewed by the OmniRx Health clinical team•Last reviewed Jul 4, 2026

    In plain language

    What SLU-PP-332 is used for

    • Studied only in preclinical models for effects on estrogen-related receptor signaling

    Taking this medicine

    How it is administered

    • Oral capsule

    Read before you decide

    Risks and precautions

    Risks and warnings

    • Gastrointestinal symptoms (nausea, bloating — extrapolated; no human data)
    • Safety profile in humans entirely unknown — no human clinical trials conducted
    • ERR agonism may have uncharacterized effects on estrogen-sensitive tissues

    Who should not take it

    • Estrogen-sensitive cancers or conditions (precautionary — ERR activity may interact with estrogen signaling)
    • Pregnancy or breastfeeding (no safety data)
    • Cardiovascular disease (safety not evaluated)

    Common questions

    Patient questions

    Can SLU-PP-332 replace exercise?

    No. SLU-PP-332 is a research compound studied only in animal models. It cannot replace the cardiovascular, musculoskeletal, and psychological benefits of physical activity. It is not FDA-approved, and its effects and safety in humans are completely unknown.

    Is SLU-PP-332 safe or legal to use?

    SLU-PP-332 is not FDA-approved and has not been evaluated in human clinical trials. There is no established safe dose for humans. It is not a dietary supplement and cannot legally be sold as one. Consult a licensed provider for evidence-based metabolic or performance support.

    Explore treatment hubs

    This information is educational — not medical advice.

    This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.